Prelude Therapeutics Incorporated Company Information
Prelude Therapeutics Incorporated's employee growth, exchange listings and data sources
Key Information
- Name: Prelude Therapeutics Incorporated
- Ticker: PRLD
- Exchange: NasdaqGS
- Founded: 2016
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$69.881m
- Shares Outstanding: 55.02m
- Website: https://preludetx.com
Number of Employees
Location
- Prelude Therapeutics Incorporated
- 175 Innovation Boulevard
- Wilmington
- Delaware
- 19805
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| PRLD | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Sep 2020 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/08 03:25 |
| End of Day Share Price | 2024/11/07 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.